1), which is consistent with previously reported decreases in acetylcarnitine in other fatigue-associated conditions and supports our hypothesis that acetylcarnitine supplementation may be beneficial in the treatment of long COVID-associated neuropsychiatric symptoms
This stack requires comprehensive baseline labs and periodic monitoring of IGF-1, metabolic markers, and NAD+-related biomarkers
You may still need to take extra creatine to reach the effective daily dose
5 How They Compare: Mechanism and Clinical Evidence Both NAC and glutathione ultimately support the same biological outcome -- higher intracellular glutathione and lower oxidative burden -- but they operate at different points in the pathway and carry different clinical evidence profiles
The available evidence remains predominantly preclinical, so findings should not be presented as proof of safety or therapeutic effectiveness in people
doi:10.1111/codi.15325 Staller K, Olen O, Soderling J, et al